Vaginal metastasis of pancreatic cancer

Vaginal metastasis of pancreatic cancer

Khadija Benhayoune^1,&, Hinde El Fatemi¹, Meryem El Ghaouti¹, Abdelaziz Bannani², Abdelilah Melhouf³, Taoufik Harmouch ¹

¹Department of Surgical Pathology, CHU Hassan II, Fez, Morocco, ²Departement of Gyneacology I, CHU Hassan II, Fez, Morocco, ³Departement of Gyneacology II, CHU Hassan II, Fez, Morocco

^&Corresponding author
Khadija Benhayoune, Department of Surgical Pathology, CHU Hassan II, Fez, Morocco

Pancreatic cancer is among the most devasting of humain malignancies. One of the major hallmarks of pancreatic cancer is its early systemic dessimination and its extraordinary local tumor progression. The usual sites of metastases in pancreatic cancer are the liver and peritoneal cavity. Other less common sites are the lung, bone and brain. Unusual sites such as muscle, skin, heart, pleura, stomach, umblicus, kidney, appendix, spermatic cord and prostate have also been reported [1-4] To our knowledge, the formation of metastases in the vagina from primary pancreatic cancer is exceptional. We report the third case in the world of a primary pancreatic adenocarcinoma discovered of symptoms from a vaginal metastasis [5,6]

70-year-old woman presented to Department of Gynecology with vaginal bleeding without other associated signs. Physical examination revealed a friable mass in the anterior wall of vagina and invading the clitoris. Bimanual pelvic examination showed that cervix, uterus and bilateral adnexal structures are normal. Speculum examination showed an ulcerative and exophytic mass, 6cm in diameter on the anterior wall of vagina at third lower. The lymph nodes are free. Transabdominal pelvic ultrasound reported that the uterus was with homogenous myometrium, indistinct endometrial echo pattern and bilateral adnexal areas were normal. Incisional biopsy was performed and reported a well-differentiated, mucinous adenocarcinoma with a complex gland pattern with areas of cribriform architecture, stratified and hyperchromatic nuclei, and moderate nuclear atypia (Figure 1). Tumor cells are immunoreactive for CK20 and CK19. They are negative for CK7, CK5/6, CK14, CD10 and hormone receptors (Figure 2, Figure 3). At the same time, an abdominopelvic CT was performed. It showed the presence of a tumor mass in the pancreatic tail (Figure 4). Response to radiological and histological findings, the diagnosis of vaginal metastasis of pancreatic cancer has been retained.

Extragenital tumor metastatic to the female genital tract is a rare occurrence. Few cases are reported in literature describing isolated metastasis to the vagina. To our knowledge, this is the first case of a reveal vaginal metastasis of pancreatic cancer. One report analysed the origin of metastases in the female genital tract; in 149 out of 325 cases, metastases originated from extra- or intragenital primaries [7,8] and they were more frequently localized in the ovaries [9,10] and vagina (Table 1). The majority of the extragenital metastases were adenocarcinomas from the gastrointestinal system, but a variety of other primaries did occasionally spread to the genital tract. Cancer metastases to the vagina from upper abdominal organs are quite rare, especially in the absence of metastatic disease to other abdominal or pelvic structures. Vaginal metastases can be difficult to detect, depending on their size and location in the vagina. So, the histological examination is essential for the positive diagnosis. Cells tumor of metastatic pancreatic adenocarcinoma show positive immunohistochemical staining for SMAD4, CK19, CK7, CK18, CK20 and CA19/9. It is diffuclt to conceptualize how a pancreatic malignancy could manifest clinically as a vaginal metastasis without evidence of other organ metastasis or significant abdominal symptoms. Metastatic tumors may appear in locations that are not in the line of direct spread from their primary focus, which is called paradoxical metastasis. When direct contiguous spread is not the case, it is speculated that remote vaginal metastasis may occur either through lymphatic or hematogenous routes. The valveless “vertebral plexus of Baston”communicates above the intracranial venous sinuses and segmentally with the veins of the thorax, abdomen and pelvis. This vertebral venous system has been well documented as a pathway of paradoxical metastasis, as in bone metastases in patients with prostate cancer and breast cancer, which were also described by Baston [11]. Because this plexus allows for tumor cells to spread in both on anterograde and retrograde fashion, we theorize that the pancreatic tumor metastasized to the vagina via this hematogenous route. Disseminated metastatic disease is frequently present in patients with vaginal metastases and the prognosis is extremely poor in these patients. Our case is exceptional. Indeed, vaginal localization was indicative of primary pancreatic tumor, without other sites. A distinction from primary vaginal adenocarcinoma of the intestinal type may be difficult. Extensive research should be performed to exclude a primary adenocarcinoma of another location because of differences prognosis and treatment. A broad immunohistochemical panel should assist in making the correct diagnosis. Although it is frequently associated with primary vaginal tumors, vaginal bleeding or discharge might be the first clinical manifestations of an occult carcinoma or clinical signs of a wide spread metastatic disease. Data on the treatment of vaginal metastasis are limited but most cases are treated with radiotherapy [12]. In the absence of any other metastatic lesion, treatment of both the primary tumor as well as the isolated metastasis should be carried out with a surgical approach and consideration for curative radiotherapy [13].

Metastases to the female genital tract from pancreatic cancer are unsual. The incidence of vagina metastases secondary to adenocarcinoma of the exocrine pancreas is unknown. Symptom producing vagina metastases are common than primary site in patients who present a metastatic adenocarcinoma of unknown origin.

The authors declare no competing interests.

All authors read and approved the final manuscript.

Table 1: metastatic tumor presenting as possible primary lesions, extragenital and genital primaries

Figure 1: well-differentiated, mucinous adenocarcinoma (HES ×4 and HES x 20)

Figure 2: CK19 and CK20 immunohistochemestry highlighting tumor cells in the well differentiated pancreas tumor

Figure 3: the tumor cells are negative for CK7

Figure 4: metastatic tumor presenting as possible primary lesions, extragenital and genital primaries

1. Wafflart E, Gibaud H, Lerat F, et al. Muscular metastases of cancer of the pancreas. J Chir (Paris). 1996 Jun;133(4):167-70. PubMed | Google Scholar


2. Otegbayo JA, Oluswasola OA, Akere A, et al. Pancreatic carcinoma presenting as cutaneous nodules in a diabetic Nigerian male. West Afr J Med. 2005 Apr-Jun;24(2):180. PubMed | Google Scholar


3. Robinson BW, Lewis RR. Myocardial metastases from carcinoma of pancreas presenting as acute myocardial infarction. J R Soc Med. 1982 Jul;75(7):560-2. PubMed | Google Scholar


4. Merseburger AS, Muller CC, Merseburger Schonborn CT, et al. A rare case of isolated prostate metastasis from primary pancreatic cancer. Urologe A. 2005 May;44(5):527-9. PubMed | Google Scholar


5. Weitzner, S and Dressner, SA. Vaginal metastasis from adenocarcinoma of the pancreas. Am Surg. 1974 Apr;40(4):256-8. PubMed | Google Scholar


6. Amanda Nickles Fader, Jennifer A Brainard, Peter G Rose. Symptomatic vaginal bleeding in a postmenopausal woman: a case report of pancreatic adenocarcinoma metastasizing exclusively to the vagina. Am J Obstet Gynecol. 2007 Nov;197(5):e8-9. PubMed | Google Scholar


7. Mazur MT, Hsueh S and Gersell DJ: metastases to the female genital tract. Analysis of 325 cases. Cancer. 1984 May 1;53(9):1978-84. PubMed | Google Scholar


8. Jahnke A, Domke R, Matovitzky J, Hizze H, Briese V. Vaginal metastases of lung cancer: a case report. Anticancer Res. 2005 May-Jun;25(3A):1645-8. PubMed | Google Scholar


9. Yeh KY, Chang JW, HusuehS, Chang TC and Lin MC. Ovarian metastasis originating from bronchoalveolar carcinoma: a rare presentartion of ling cancer. Jpn J Clin Oncol. 2003 Aug;33(8):404-7. PubMed | Google Scholar


10. House Holder J, Han A, Edelson MI, Eager JM and Rosenblum NG. immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovaries. Arch Pathol Lab Med. 2002 Sep;126(9):1101-3. PubMed | Google Scholar


11. Geldof, A A. Models for cancer skeletal metastasis: a reappraisal of Batson's plexus. Anticancer Res. 1997 May-Jun;17(3A):1535-9. PubMed | Google Scholar


12. Filippo Bellati, Innocenza Palaia, Maria Luisa Gasparri, Angela Musella, Pierluigi, Benedetti Panici. First case of isolated vaginal metastasis from breast cancer treated by surgery. BMC Cancer. 2012 Oct 17;12(1):479. PubMed | Google Scholar


13. Queiroz C, Bacchi CE, Oliveire C, Carvalho M, Santos DR. Cytologic diagnosis of vaginal metastasis from renal cell carcinoma - a case report. Acta Cytol. 1999 Nov-Dec;43(6):1098-100. PubMed | Google Scholar